Flamma is a privately held, family run and owned CDMO with experience from 1950. The Flamma Group offers a unique opportunity to accelerate your small molecule drug development by shortening the timeline to the pharmaceutical marketplace. With the ability to leverage FDA inspected cGMP Italian production facilities along  a GMP site in the USA coupled with its 100% owned and run GMP Chinese facility, Flamma provides a stable, secure supply chain for small molecule Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCEs), Registered Starting Materials (RSMs) and Key Intermediates from early-stage needs to commercial delivered materials. Flamma is an award winning CDMO most recently being named a Top 10 CMO in Europe by Pharma Tech Outlook. Other awards include the CDMO Leadership Award where Flamma recorded 3 straight years of being recognized as a Top Performer in all 6 CDMO Core Award Categories: Expertise, Reliability, Capabilities, Quality, Service and Compatibility. Flamma was also recognized as a Top Performer in all 7 Specialty Award Categories:  Accessible Senior Management, State-of-the-Art, Innovation, On-Time Delivery, Right the First Time, Strength of Science, and Reputation. There were 110 CDMOs evaluated on 23 performance metrics by pharma industry sourcing professionals. Of these 110 CDMOs, Flamma was the ONLY small molecule CDMO that was rated as a TOP PERFORMER in all core & specialty categories.